2-(Pyridin-2-ylsulfanyl)-N-(2,4,5-trifluorophenyl)acetamide

Catalog No. :
ACCYNG126
CAS No. :
868256-37-5
Molecular Formula :
C13H9F3N2OS
Molecular Weight :
298.29

IUPAC Name:2-(pyridin-2-ylthio)-N-(2,4,5-trifluorophenyl)acetamide

2-(Pyridin-2-ylsulfanyl)-N-(2,4,5-trifluorophenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$186.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Pyridin-2-ylsulfanyl)-N-(2,4,5-trifluorophenyl)acetamide
IUPAC Name2-(pyridin-2-ylthio)-N-(2,4,5-trifluorophenyl)acetamide
MDL No.MFCD05150540
Molecular FormulaC13H9F3N2OS
Molecular Weight298.29
SMILESO=C(NC1=CC(F)=C(F)C=C1F)CSC2=NC=CC=C2
InChI KeyYYAQFTUYWHXQPI-UHFFFAOYSA-N
SynonymSALOR-INT L322377-1EA;2-(2-PYRIDINYLSULFANYL)-N-(2,4,5-TRIFLUOROPHENYL)ACETAMIDE;2-(pyridin-2-ylsulfanyl)-N-(2,4,5-trifluorophenyl)acetamide;Acetamide, 2-(2-pyridinylthio)-N-(2,4,5-trifluorophenyl)-
CAS No.868256-37-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCYNG126 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVMGT218 route compound structure diagram
    ACVMGT2182637-34-5 In Stock
  4. Then
  5. ACCYNG126 route product structure diagram
    ACCYNG126868256-37-5
Inquiry

2. ACCYNG126 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQDUF917 route compound structure diagram
    ACQDUF917367-34-0 In Stock
  2. Plus
  3. ACHDNK468 route compound structure diagram
    ACHDNK46810002-29-6 In Stock
  4. Then
  5. ACCYNG126 route product structure diagram
    ACCYNG126868256-37-5
Inquiry

Comments (0)